Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aptose Biosciences Inc. | 613,252 | reported | 25 Nov 2024 | tx 23+5,512,129−168,891 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Nov 2024 | PURCHASE | Aptose Biosciences Inc. | 100,000 | 0.20 USD | first after silence |
| 25 Nov 2024 | PURCHASE | Aptose Biosciences Inc. | 50,000 | — | deriv |
| 05 Feb 2024 | GRANT_AWARD | Aptose Biosciences Inc. | 70,000 | 0.00 USD | deriv |
| 19 Jan 2023 | GRANT_AWARD | Aptose Biosciences Inc. | 150,000 | 0.00 USD | |
| 19 Jan 2023 | GRANT_AWARD | Aptose Biosciences Inc. | 400,000 | 0.00 USD | deriv |
| 19 Sept 2022 | PURCHASE | Aptose Biosciences Inc. | 10,000 | 0.68 USD | anomaly |
| 06 Jul 2022 | GRANT_AWARD | Aptose Biosciences Inc. | 600,000 | 0.00 USD | deriv |
| 06 Jun 2022 | PURCHASE | Aptose Biosciences Inc. | 10,000 | 0.97 USD | anomaly |
| 18 Jan 2022 | GRANT_AWARD | Aptose Biosciences Inc. | 700,000 | 0.00 USD | deriv |
| 16 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 13,183 | 1.52 USD | |
| 15 Dec 2021 | PURCHASE | Aptose Biosciences Inc. | 17,822 | 1.12 USD | |
| 26 Nov 2021 | PURCHASE | Aptose Biosciences Inc. | 8,643 | 2.31 USD | |
| 02 Jul 2021 | PURCHASE | Aptose Biosciences Inc. | 6,081 | 3.29 USD | first after silence |
| 04 Jan 2021 | GRANT_AWARD | Aptose Biosciences Inc. | 343,000 | 0.00 USD | deriv |
| 10 Jul 2020 | SALE | Aptose Biosciences Inc. | 168,891 | 6.05 USD | |
| 25 Mar 2020 | PURCHASE | Aptose Biosciences Inc. | 3,400 | 5.82 USD | |
| 10 Mar 2020 | GRANT_AWARD | Aptose Biosciences Inc. | 300,000 | 0.00 USD | |
| 31 Jan 2020 | GRANT_AWARD | Aptose Biosciences Inc. | 2,000,000 | 0.00 USD | deriv |
| 24 Oct 2019 | PURCHASE | Aptose Biosciences Inc. | 10,000 | 1.92 USD | |
| 18 Apr 2019 | PURCHASE | Aptose Biosciences Inc. | 10,000 | 1.85 USD | anomaly |
| 14 Mar 2019 | PURCHASE | Aptose Biosciences Inc. | 10,000 | 1.90 USD | |
| 02 Jan 2019 | GRANT_AWARD | Aptose Biosciences Inc. | 400,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 25 Nov 2024.